Statizoid

Fiji vs Tonga: Statin use vs. average non-HDL cholesterol levels

Fiji
3.8
in 2018
Tonga
3.8
in 2018
Fiji rank
6th
Tonga rank
6th

Statin use vs. average non-HDL cholesterol levels over time

  • Fiji
  • Tonga
01234198019992018

How they compare

Fiji currently reports 3.8 against 3.8 in Tonga, a difference of 0.

The two have swapped places 1 time across 39 shared years of data; in 1980 it was Fiji ahead.

Fiji ranks 6th and Tonga ranks 6th of 191 countries.

Individual pages

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.